All sponsors

Sichuan Huiyu Pharmaceutical Co., Ltd

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-30
RECRUITING5
READOUTS ≤12 MONTHS3
READOUT SLIPPED >6 MO60%

Delay Index: of 5 active trials registered more than a year ago, 3 have moved their primary completion (readout) date by more than 6 months since first registration (median +12.0 months). See all sponsors →

Open Sichuan Huiyu Pharmaceutical Co., Ltd on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Test product: HYP-2090PTSA
NCT06243354
P1/2RecruitingSafety; Tolerability2572026-12 (+12 mo)
Test Product HY07121
NCT06639256
P1/2RecruitingSafety; Tolerability2582027-05-26 (+13 mo)
Test product HY0001a for injection
NCT07069062
P1/2RecruitingSolid Tumor2612027-06 (+4 mo)
HY05350 for injection
NCT07083323
P1/2RecruitingAdvanced Solid Tumor2622028-03-31
Test Product HY07121 for Injection (Subcutaneous)
NCT07789327
P1/2Not yet recruitingSafety; Tolerability2542028-04
Test Product HYP-6589
NCT06712680
P1/2RecruitingSolid Tumor1152028-04-10 (+21 mo)